Holen Sie sich die Stockscreener-App
25.61
0.22%
-16.47
Flexion Therapeutics, Inc. Aktie (FLXN) Neueste Nachrichten
Joint Pain Injections Market Overview and Leading Players: - openPR.com
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates - Finviz
Flexion Therapeutics, Inc.Common Stock (NQ: FLXN - FinancialContent
Flexion Therapeutics Announces Publication of Analysis of Patients with Unilateral Knee OA from Pivotal Trial of ZILRETTA® (... - ADVFN
Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Updates - ADVFN
Flexion Therapeutics Announces Publication of Independent Data Review of ZILRETTA® (triamcinolone acetonide extended-release... - ADVFN
Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (... - ADVFN
Osteoarthritis Therapeutics Market Size to Hit USD 26.31 billion by 2035 - Precedence Research
Anti-Inflammatory Therapeutics Market Size to Hit USD 164.44 Bn by 2035 - Precedence Research
Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Globe and Mail
Musculoskeletal Pain Treatment Market Size (7MM) is expected to grow at a significant CAGR by 2034, estimates DelveInsight - The Globe and Mail
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - pharmiweb.com
Musculoskeletal Pain Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight - openPR.com
Osteoarthritis Gene Therapy Market Research Report 2025 - InsightAce Analytic
Knee Osteoarthritis Pipeline Drugs Insights Report 2025: Emerging Therapeutics and Market Opportunities Revealed | DelveInsight - The Globe and Mail
Knee Osteoarthritis Pipeline Drugs Insights Report 2025: - openPR.com
Swollen Knee Treatment Market Expands as Demand for Non-Invasive Therapies Accelerates Globally - newstrail.com
Cipher Mining Inc.Common Stock (NQ: CIFR - FinancialContent
Knee osteoarthritis Market: Epidemiology, Therapies, Companies, DelveInsight | Centrexion Therapeutics, Pfizer, Eli Lilly, Ampio Pharmaceuticals, Galapagos NV, Cytonics, Flexion Therapeutics - Barchart.com
Knee Osteoarthritis Pipeline Analysis 2025: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight - The Globe and Mail
Postoperative Pain Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight - openPR.com
Non-opioid pain drug maker Pacira lays off 71 in California, retires facility in manufacturing upgrade - Fierce Pharma
Postoperative Pain Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight Allay Therapeutics, Siteone Therapeutics, Lipocure, Flexion Therapeutics - MenaFN
T-knife Therapeutics Appoints Christoph Broja to its Board of Directors - GlobeNewswire
Non-Opioid Pain Treatment Market Size, Share | CAGR Of 8.1% - Market.us
High Costs of Knee Osteoarthritis Treatment - Market.us
Knee Osteoarthritis (OA) Injectable Treatments Market Revenue to Attain USD 5.94 Bn by 2033 - Precedence Research
Syncromune Appoints Kerri-Ann Millar as Chief Financial Officer - citybiz
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer - GlobeNewswire
Marquis Who's Who Honors Shomari Hogan, MD, for Expertise in Consulting Services - 24-7 Press Release Newswire
Osteoarthritis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Revenue, Statistics, Therapies, and Companies by DelveInsight - Barchart.com
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz - Endpoints News
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire
From bench to bedside: Osteoarthritis gene therapy developed in the lab at Baylor is in clinical trials nationwide - Baylor College of Medicine Blog Network -
Gene Therapies For Rare Diseases Market Share, Size, Growth and Forecast to 2031 - Insightace Analytic
Global Non-Steroidal Anti-Inflammatory Drugs Market is - GlobeNewswire
Avalo Therapeutics Welcomes Chief Medical Officer - Contract Pharma
Madison Topic FLEXION THERAPEUTICS, INC. | News, Weather, Sports, Breaking News - WMSN
Osteoarthritis Injectables Market Size & Share Report, 2030 - Grand View Research
U.S. Osteoarthritis Injectables Market | Industry Report, 2030 - Grand View Research
Global Medical Dynamometers Market to Witness Upsurge in Growth at a CAGR of ~6% by 2030 | DelveInsight - PR Newswire
Postoperative Pain Market is Projected to Grow at a CAGR of 7.2% by 2032 | DelveInsight - GlobeNewswire
Apnimed Appoints John Yee, MD, MPH, as SVP, Medical Affairs - GlobeNewswire
Is Osteoarthritis Cure — ARPA-H NITRO — Rocket Fuel Or TNT? - Clinical Leader
Knee Osteoarthritis Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies To Look OutTechfields, Centrexion, Biosplice, Ampio, Paradigm, Grünenthal, Naturecell, MiMedx, TissueTech, Organogenesis - Yahoo Finance
Joint Pain Injections Market Trends, Forecast, and Consumer Insights - SkyQuest Technology
Joint Pain Injection Market 2021Latest Trends, Technological Advancement, Growth Drivers and Forecast To 2028 - openPR.com
Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic - PR Newswire
Global Joint Pain Injections Market Size & Share Revenue Is - GlobeNewswire
Osteoarthritis Therapeutics Market to Register a Steady CAGR of 8.70% Between 20222030 - Digital Journal
Versant Development Fund Iii, L.p. Net Worth (2025) - GuruFocus
Utpal Koppikar named Alphabet health firm Verily CFO - The American Bazaar
Indian American Utpal Koppikar Named CFO of Alphabet Precision Health Company Verily - American Kahani
Verily Appoints Utpal Koppikar as Chief Financial Officer - FinancialContent
Mark S. Levine Net Worth (2025) - GuruFocus
Anti-Inflammatory Therapeutics Market Size To Hold USD 127.5 Bn By 2030 - BioSpace
Pacira survey finds knee pain hurts physically, socially and mentally - Fierce Pharma
Patrick J Mahaffy Net Worth (2025) - GuruFocus
Global Joint Pain Injections Market is Expected to Generate $13.2 Billion by 2031: Allied Market Research - GlobeNewswire
Joint Pain Injections Market Size, Share | Forecast2031 - Allied Market Research
Rich Insights into the Knee Osteoarthritis Clinical Trial Analysis Featuring 60+ Companies and Therapies | DelveInsight - GlobeNewswire
Allergy Partners Announces Collaboration with Aimmune Therapeutics to Provide PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Directly to Patients - Business Wire
Agios Appoints Rahul Ballal and Cynthia Smith to Board of Directors - citybiz
Mass. biotechs have cut thousands of jobs so far in 2022. Here's a list. - The Business Journals
BioSpace Movers & Shakers, April 1 - BioSpace
PCRX Stock Price and Chart — NASDAQ:PCRX - TradingView — Track All Markets
After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees - Endpoints News
Two more Cambridge biotechs cutting staff - The Business Journals
2.90%
Kapitalisierung:
|
Volumen (24h):